This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

William J. Meggs, MD, PhD
East Carolina University Greenville, NC

JAMA. 1997;277(10):787.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Readers of the article by Dr Grossman and colleagues¹ cannot be enlightened to the answer of the question of whether a moratorium should be placed on the use of sublingual nifedipine capsules in hypertensive emergencies. What is clear is that there should be a moratorium on articles, such as this one, that do not contain the information needed to answer the question posed. The authors give as rationale for a moratorium 16 case reports from the literature of diverse adverse events temporally associated with nifedipine use, including paralysis, arrhythmias, myocardial infarction (MI), abdominal complaints, and syncope. However, it is impossible to know if administration of nifedipine was causative (for example, in the death of the patient who was given nifedipine for unstable angina and died of an MI because some patients with unstable angina die of MI without the administration of nifedipine).

Furthermore, the authors do not know the . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?